Annual report pursuant to Section 13 and 15(d)

Consolidated Condensed Balance Sheets (Parenthetical)

v3.24.1
Consolidated Condensed Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Accounts Receivable, Allowance $ 151 $ 0
Stockholders' equity:    
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 300,000,000 300,000,000
Common stock, shares issued (in shares) 145,232,000 121,938,000
Common stock shares outstanding (in shares) 142,837,000 119,508,000